{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:42:16Z","timestamp":1787643736401,"version":"build-2736575974"},"reference-count":21,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.2967\/jnumed.115.165050","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T03:59:05Z","timestamp":1452225545000},"page":"517-523","source":"Crossref","is-referenced-by-count":50,"title":["Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients"],"prefix":"10.2967","volume":"57","author":[{"given":"Wolfgang P.","family":"Fendler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Todica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolin J.","family":"Paprottka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp M.","family":"Paprottka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias F.","family":"Jakobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Michl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"2021051712090009000_57.4.517.1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn233"},{"key":"2021051712090009000_57.4.517.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-005-9039-1"},{"key":"2021051712090009000_57.4.517.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.06.024"},{"key":"2021051712090009000_57.4.517.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2007.02.019"},{"key":"2021051712090009000_57.4.517.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.03.056"},{"key":"2021051712090009000_57.4.517.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.096230"},{"key":"2021051712090009000_57.4.517.7","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2472062029"},{"key":"2021051712090009000_57.4.517.8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23339"},{"key":"2021051712090009000_57.4.517.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2008.01.009"},{"key":"2021051712090009000_57.4.517.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2014.07.007"},{"key":"2021051712090009000_57.4.517.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-3658-7"},{"key":"2021051712090009000_57.4.517.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.116426"},{"key":"2021051712090009000_57.4.517.13","unstructured":"Karnofsky DA Burchenal JH . The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM , ed. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University Press; 1949:196."},{"key":"2021051712090009000_57.4.517.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.11.060"},{"key":"2021051712090009000_57.4.517.15","unstructured":"Common terminology criteria for adverse events, version 4.0. EORTC website. http:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Updated June 14, 2010. Accessed January 20, 2016."},{"key":"2021051712090009000_57.4.517.16","first-page":"2357","article-title":"A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study","volume":"7","author":"Guadagni","year":"2001","journal-title":"Clin Cancer Res."},{"key":"2021051712090009000_57.4.517.17","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930230311"},{"key":"2021051712090009000_57.4.517.18","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3436-1"},{"key":"2021051712090009000_57.4.517.19","doi-asserted-by":"publisher","DOI":"10.1038\/416279a"},{"key":"2021051712090009000_57.4.517.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-013-0579-1"},{"key":"2021051712090009000_57.4.517.21","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e318266cd08"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.115.165050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:07:51Z","timestamp":1621282071000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.115.165050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,1]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.2967\/jnumed.115.165050"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.115.165050","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]}}}